The aim of the proposed study is to obtain insight into the temporal dynamics of functional reorganization and cognition, and to assess the effect of cognitive rehabilitation on this adaptive mechanism and cognitive functioning.
ID
Source
Brief title
Condition
- Demyelinating disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
1) Changes in brain activation and networks in relationship with cognitive
decline (5 year follow-up)
2) Changes in cognitive function after attention training
3) Changes in brain activation and networks in relationship after attention
training
Secondary outcome
- The effect of cognitive rehabilitation on subjective cognitive functioning
Background summary
Cognitive impairment is a frequent and highly disabling complaint in multiple
sclerosis (MS). Important new insights into the pathophysiology of MS cognitive
impairment have been gained, which are consistent with a *functional
reorganization model*. This model implies that cognitive impairment is preceded
by reorganization of brain function (as measured with functional magnetic
resonance imaging (MRI)) and is regarded as a crucial compensatory mechanism
that counterbalances on-going brain damage and delays the onset of MS cognitive
decline. However, longitudinal studies are crucially lacking and required to
understand the temporal dynamics of this compensatory mechanism. Recently,
it-has been shown that functional reorganization can be enhanced via cognitive
intervention, which might have beneficial effects on patients* cognitive
functioning.
Study objective
The aim of the proposed study is to obtain insight into the temporal dynamics
of functional reorganization and cognition, and to assess the effect of
cognitive rehabilitation on this adaptive mechanism and cognitive functioning.
Study design
The proposed study is a 5-year follow-up of a well-defined cohort of 85
subjects (35 cognitively preserved (CP) and 20 cognitively impaired (CI) MS
patients, 30 healthy controls). In the initial study, subjects received
detailed neuropsychological testing and structural and functional MRI, which
will be repeated for the follow-up study. Subsequently, a well-established
cognitive rehabilitation program focusing on attention will be offered to the
MS patients. Its effect on cognitive improvement and/or changes in functional
reorganization will be assessed directly after intervention (short-term) and 3
months after intervention (long-term).
Intervention
A computer-based attention training will be provided for 7 weeks (once a week,
45 minutes per session) in the experimental group. The control group (waiting
list) will not engage in any cognitive rehabilitation program
Study burden and risks
All subjects will visit our outpatient clinic to undergo neuropsychological
testing (approximately 60 minutes) and MRI scanning (approximately 70 minutes).
Patients are asked to participate in the cognitive rehabilitation program, for
which they have to visit the outpatient clinic directly after intervention
(same measures as first visit) and 3 months post intervention (only
neuropsychological testing). Prior to each measurement, subjects have to fill
in several questionnaires at home (approximately 30 minutes). Additionally,
patients will undergo EDSS examination by telephone. The congitive
rehabilitation program will last for 7 weeks, and patients have to train once a
week for 45 minutes. Therefore, the burden for patients is relatively low.
There are no risks associated with participation, becasue MRI is a safe
technique (subjects will be screened for exclusion criteria and earplugs will
be provided to reduce scanner noise) and no adverse effects are expected
related to the cognitive rehabilitation program.
Van der Boechorststraat 7
Amsterdam 1081BT
NL
Van der Boechorststraat 7
Amsterdam 1081BT
NL
Listed location countries
Age
Inclusion criteria
- Clinically definite MS
- Age between 18-68 years
- Meet safety criteria to undergo MRI examination
- Sufficient motor skills
Exclusion criteria
- History of drug abuse
- Neurological diseases (for paitents: other than MS)
- Psychiatric diseases
- For patients: relapse free and steroid treatment free for at least 4 weeks prior to examination
-For patients: not allowed to participate in other intervention studies while they are participating in this study
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL50248.029.14 |